| T. Rowe Price Capital Appreciation | PRWCX | 38.61 | +0.29% | 34.97B | 21/11 | |
| T. Rowe Price Blue Chip Growth | TRBCX | 200.74 | +0.05% | 31.42B | 21/11 | |
| T. Rowe Price Capital Appreciation I | TRAIX | 38.64 | +0.29% | 29.37B | 21/11 | |
| T. Rowe Price Blue Chip Growth I | TBCIX | 202.05 | +0.05% | 29.8B | 21/11 | |
| T. Rowe Price Instl Large Cap Growth | TRLGX | 86.29 | +0.17% | 22.67B | 21/11 | |
| T. Rowe Price Growth Stock I | PRUFX | 111.54 | -0.01% | 15.11B | 21/11 | |
| T. Rowe Price Dividend Growth | PRDGX | 82.70 | +0.99% | 13B | 21/11 | |
| T. Rowe Price Mid-Cap Growth I | RPTIX | 112.90 | +1.61% | 12.9B | 21/11 | |
| T. Rowe Price Growth Stock | PRGFX | 111.08 | -0.01% | 12.26B | 21/11 | |
| T. Rowe Price Mid-Cap Growth | RPMGX | 112.54 | +1.61% | 12.1B | 21/11 | |
| T. Rowe Price Dividend Growth I | PDGIX | 82.67 | +0.99% | 11.47B | 21/11 | |
| T. Rowe Price Equity Index 500 I | PRUIX | 156.75 | +0.55% | 10.22B | 21/11 | |
| T. Rowe Price New Horizons I | PRJIX | 62.60 | +1.89% | 10.21B | 21/11 | |
| T. Rowe Price Health Sciences | PRHSX | 94.05 | +0.31% | 8.77B | 21/11 | |
| T. Rowe Price Equity Income | PRFDX | 39.10 | +0.83% | 8.43B | 21/11 | |
| T. Rowe Price Equity Income I | REIPX | 39.06 | +0.80% | 8.67B | 21/11 | |
| T. Rowe Price New Horizons | PRNHX | 62.16 | +1.87% | 8.24B | 21/11 | |
| T. Rowe Price New America Growth | PRWAX | 81.43 | +0.69% | 8.11B | 21/11 | |
| T. Rowe Price Equity Index 500 | PREIX | 156.72 | +0.55% | 8.1B | 21/11 | |
| T. Rowe Price Capital Opportunity | PRCOX | 59.24 | +0.53% | 6.54B | 21/11 | |